Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng Cheng

Showing results (981-990 of 1,016) with videos related to

Pageof 102
Sort By:
Biomaterials|July 12, 2024
Bioactive sucralfate-based microneedles promote wound healing through reprogramming macrophages and protecting endogenous growth factorsZhicheng Le, Mayk Caldas Ramos, Yufeng Shou, et al.
Advanced Healthcare Materials|November 21, 2023
Attenuating Epithelial-to-Mesenchymal Transition in Cancer through Angiopoietin-Like 4 Inhibition in a 3D Tumor Microenvironment ModelZehuan Liao, Joseph Jing Heng Lim, Jeannie Xue Ting Lee, et al.
Nature Communications|March 28, 2026
Single-bacterial cell insights into mechanisms of ceftriaxone resistance in Neisseria subflavaXin Zhang, Hong Sheng Cheng, Xueliang Zhan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 26, 2026
REGγ Suppresses Ferroptosis and Induces Drug Resistance by Degrading WDR6 in ChondrosarcomaFanrong Liu, Shihui Shen, Dongxia Li, et al.
Hepatology International|August 12, 2009
Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: identification of potential high HCV endemic areasWei-Wen Su, Chien-Hung Chen, Hans Hsienhong Lin, et al.
Cell Death and Differentiation|April 22, 2020
Deficiency in fibroblast PPARβ/δ reduces nonmelanoma skin cancers in miceMark Wei Yi Tan, Ming Keat Sng, Hong Sheng Cheng, et al.
The Journal of Pathology|April 14, 2026
Cellular origins and etiological factors for squamous cell carcinoma and related cancer types of the bladderXianbin Su, Xuehui Duan, Shihao Bai, et al.
Journal of Translational Medicine|January 13, 2025
A humanized anti-MSLN×4-1BB bispecific antibody exhibits potent antitumour activity through 4-1BB signaling activation and fc function without systemic toxicityDa-Yan Zhang, Zhi-Hua Zhang, Wen-Ting Liu, et al.
Bioorganic Chemistry|April 19, 2025
Unlocking the potential of novel tetrahydro-β-carboline-based HDAC6 inhibitors for colorectal cancer therapy: Design, synthesis and biological evaluationNoreen Hemida, Dalia S El-Gamil, Ahmed K ElHady, et al.
RSC Medicinal Chemistry|April 21, 2025
Development of potent and selective tetrahydro-β-carboline-based HDAC6 inhibitors with promising activity against triple-negative breast cancerAya Fathy, Amro Allam, Ahmed K ElHady, et al.
Pageof 102

Showing results (981-990 of 1,016) with videos related to

Sort By:
Pageof 102
Biomaterials|July 12, 2024
Bioactive sucralfate-based microneedles promote wound healing through reprogramming macrophages and protecting endogenous growth factorsZhicheng Le, Mayk Caldas Ramos, Yufeng Shou, et al.
Advanced Healthcare Materials|November 21, 2023
Attenuating Epithelial-to-Mesenchymal Transition in Cancer through Angiopoietin-Like 4 Inhibition in a 3D Tumor Microenvironment ModelZehuan Liao, Joseph Jing Heng Lim, Jeannie Xue Ting Lee, et al.
Nature Communications|March 28, 2026
Single-bacterial cell insights into mechanisms of ceftriaxone resistance in Neisseria subflavaXin Zhang, Hong Sheng Cheng, Xueliang Zhan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 26, 2026
REGγ Suppresses Ferroptosis and Induces Drug Resistance by Degrading WDR6 in ChondrosarcomaFanrong Liu, Shihui Shen, Dongxia Li, et al.
Hepatology International|August 12, 2009
Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: identification of potential high HCV endemic areasWei-Wen Su, Chien-Hung Chen, Hans Hsienhong Lin, et al.
Cell Death and Differentiation|April 22, 2020
Deficiency in fibroblast PPARβ/δ reduces nonmelanoma skin cancers in miceMark Wei Yi Tan, Ming Keat Sng, Hong Sheng Cheng, et al.
The Journal of Pathology|April 14, 2026
Cellular origins and etiological factors for squamous cell carcinoma and related cancer types of the bladderXianbin Su, Xuehui Duan, Shihao Bai, et al.
Journal of Translational Medicine|January 13, 2025
A humanized anti-MSLN×4-1BB bispecific antibody exhibits potent antitumour activity through 4-1BB signaling activation and fc function without systemic toxicityDa-Yan Zhang, Zhi-Hua Zhang, Wen-Ting Liu, et al.
Bioorganic Chemistry|April 19, 2025
Unlocking the potential of novel tetrahydro-β-carboline-based HDAC6 inhibitors for colorectal cancer therapy: Design, synthesis and biological evaluationNoreen Hemida, Dalia S El-Gamil, Ahmed K ElHady, et al.
RSC Medicinal Chemistry|April 21, 2025
Development of potent and selective tetrahydro-β-carboline-based HDAC6 inhibitors with promising activity against triple-negative breast cancerAya Fathy, Amro Allam, Ahmed K ElHady, et al.
Pageof 102